United Therapeutics | UTHR - Eps Gewinn Pro Aktie

Aktienkurs
587.81
Täglich Wechseln
7.30 1.26%
Monatlich
10.83%
Jährlich
106.79%
Q2 Prognose
556.12

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30




Eps Veränderung Datum
Amarin USD 0.14 0.06 2025-12
Ardelyx USD 0 0 2025-12
Baxter International USD 0.44 0.25 2025-12
Bayer EUR 0.62 0.05 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Emergent BioSolutions USD -0.77 0.29 2023-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
J&J USD 2.7 0.24 2026-03
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Moderna USD -2.11 1.6 2025-12
Omeros USD -1.12 0.37 2024-06
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sarepta Therapeutics USD -3.58 3.45 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12